Dangos 21 - 40 canlyniadau o 109 ar gyfer chwilio '"radiopharmaceutical"', amser ymholiad: 0.05e Mireinio'r Canlyniadau
  1. 21
  2. 22

    Performance evaluation of Gallium-68 radiopharmaceuticals production using liquid target PETtrace 800 cyclotron gan Ashhar, Zarif, Ahmad Fadzil, Muhammad Fakhrurazi, Md Safee, Zaitulhusna, Aziz, Firdaus, Ibarhim, Ummi Habibah, Nik Afinde, Nik Muhammad Fitri, Mat Ail, Noratikah, Jamal Harizan, Muhammad Ali Hazizi, Halib, Dzulieza, Alek Amran, Arieffuddin, Adawiyah, Rabiatul, Abd Hamid, Mohd Hamdi Noor, Mahamood, Mazurin, Razali, Nor Idayu, Said, Mohamad Aminudin

    Cyhoeddwyd 2024
    “...Due to increased demand, cyclotron has an expanding role in producing Gallium-68 (68Ga) radiopharmaceuticals using solid and liquid targets. Though the liquid target produces lower end-of-bombardment activity compared to the solid target, our study presents the performance of 68Ga radiopharmaceuticals production using the liquid target by evaluating the end-of-bombardment activity and the end-of-purification activity of 68GaGaCl3. ...”
    Erthygl
  3. 23
  4. 24

    Synthesis of 99mTc-HYNIC-interleukin-12, a new specific radiopharmaceutical for imaging T lymphocytes. gan Annovazzi, A, D'Alessandria, C, Bonanno, E, Mather, S, Cornelissen, B, van de Wiele, C, Dierckx, R, Mattei, M, Palmieri, G, Scopinaro, F, Signore, A

    Cyhoeddwyd 2006
    “... PURPOSE: Few radiopharmaceuticals have been described for the study of lymphocyte trafficking despite its high clinical relevance. ...”
    Journal article
  5. 25

    Fundamentals of nuclear pharmacy / gan 245373 Saha, Gopal B.

    Cyhoeddwyd 2004
    Pynciau: “...Radiopharmaceuticals...”
  6. 26
  7. 27
  8. 28

    Understanding the anti-tumour immune response to radionuclide therapy using PSMA targeting radiopharmaceuticals in a prostate cancer model gan Anderson, R

    Cyhoeddwyd 2021
    “...This enabled evaluation of the immune response to the clinically relevant radiopharmaceutical [177Lu]-PSMA-I&T. Using this model, I was able to show for the first time that [177Lu]PSMA-I&T is capable of inducing changes to the TIME, with a notable reduction in immune cells 72 hours post treatment followed by a return to no-treatment levels by day 12 with a trend towards an increase. ...”
    Traethawd Ymchwil
  9. 29

    Cyclotron production of Gallium-68 Radiopharmaceuticals using the 68Zn(p,n)68Ga reaction and their regulatory aspects gan Ashhar, Zarif, Ahmad Fadzil, Muhammad Fakhrurazi, Othman, Muhamad Faiz, Yusof, Nor Azah, Abdul Onny, Muhammad Adib, Mat Ail, Noratikah, Abd Rahman, Siti Fatimah

    Cyhoeddwyd 2022
    “...The use of medical cyclotrons for radiometal production can increase the availability of gallium-68 (68Ga) radiopharmaceuticals. Although generators have greatly influenced the demand for 68Ga radiopharmaceuticals, the use of medical cyclotrons is currently being explored. ...”
    Erthygl
  10. 30

    Assessing the influence of neglected GC-FID variables on the multiple responses using multivariate optimization for the determination of ethanol and acetonitrile in radiopharmaceuticals gan Hassan, Hishar, Othman, Muhammad Faiz, Zakaria, Zainul Amiruddin, Ahmad Saad, Fathinul Fikri, Abdul Razak, Hairil Rashmizal

    Cyhoeddwyd 2021
    “...Therefore, the proposed method is relevant for routine quality control analysis of all 18F-radiopharmaceutical derivatives for the direct determination of ethanol and acetonitrile....”
    Erthygl
  11. 31
  12. 32
  13. 33

    Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the Auger electron emitting radiopharmaceutical 111In-DTPA human epidermal growth factor. gan Bailey, K, Costantini, D, Cai, Z, Scollard, D, Chen, Z, Reilly, R, Vallis, K

    Cyhoeddwyd 2007
    “...UNLABELLED: (111)In-DTPA-human epidermal growth factor ((111)In-DTPA-hEGF [DTPA is diethylenetriaminepentaacetic acid]) is an Auger electron-emitting radiopharmaceutical that targets EGF receptor (EGFR)-positive cancer. ...”
    Journal article
  14. 34
  15. 35

    Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast ca... gan Chen, P, Cameron, R, Wang, J, Vallis, K, Reilly, R

    Cyhoeddwyd 2003
    “...A strong inverse relationship was observed between radiopharmaceutical uptake and tumor size, with small tumors (<5 mm(3)) accumulating >30% of the injected dose (%ID) per gram, compared with 5 %ID/g for tumors measuring 6-30 mm(3). ...”
    Journal article
  16. 36

    Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide. gan Isidori, A, Kaltsas, G, Frajese, V, Kola, B, Whitelocke, R, Plowman, P, Britton, K, Monson, J, Grossman, AB, Besser, G

    Cyhoeddwyd 2002
    “...The orbit and its contents appear to be a common site for carcinoid metastasis, and radiopharmaceutical imaging with labeled octreotide is useful in identifying many of these lesions....”
    Journal article
  17. 37

    Pituitary imaging using a labelled somatostatin analogue in acromegaly. gan Ur, E, Mather, S, Bomanji, J, Ellison, D, Britton, K, Grossman, AB, Wass, J, Besser, G

    Cyhoeddwyd 1992
    “...RESULTS: Twelve of the acromegalic subjects showed significant uptake of the radiopharmaceutical in the pituitary fossa. Of the eight patients in whom we assessed acute GH responses, five demonstrated a significant fall in GH in response to octreotide. ...”
    Journal article
  18. 38

    Osseous abnormalities associated with collateral desmopathy of the distal interphalangeal joint: part 1. gan Dakin, S, Dyson, S, Murray, R, Tranquille, C

    Cyhoeddwyd 2009
    “...CONCLUSIONS: A variety of osseous lesions of differing severity are associated with CL injury. Normal radiopharmaceutical uptake does not preclude significant osseous pathology associated with CL injury. ...”
    Journal article
  19. 39

    Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation gan Owen, J, Thomas, E, Menon, J, Gray, M, Skaripa-Koukelli, I, Gill, MR, Wallington, S, Miller, RL, Vallis, KA, Carlisle, R

    Cyhoeddwyd 2019
    “...By combining acoustic-cavitation-sensitive liposomes with radiopharmaceuticals this research represents a new concept in achieving targeted delivery of radiopharmaceuticals....”
    Journal article
  20. 40

    A STUDY OF CORE ELECTRON-BINDING ENERGIES IN TC-99M COMPLEXES BY INTERNAL-CONVERSION ELECTRON-SPECTROSCOPY gan Burke, J, Archer, C, Chiu, K, Latham, I, Egdell, R

    Cyhoeddwyd 1991
    “...The role of ICES in characterizing radiopharmaceutical agents is illustrated with studies of some novel 99mTcphosphine complexes that have been developed for myocardial perfusion imaging. © 1991....”
    Journal article